Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for MAIA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 27.60M
March 31, 2026 34.41M
December 31, 2025 8.658M
September 30, 2025 10.89M
June 30, 2025 10.14M
March 31, 2025 10.86M
December 31, 2024 9.601M
September 30, 2024 8.691M
June 30, 2024 11.58M
March 31, 2024 8.271M
Date Value
December 31, 2023 7.151M
September 30, 2023 6.105M
June 30, 2023 9.146M
March 31, 2023 7.586M
December 31, 2022 10.95M
September 30, 2022 14.06M
June 30, 2022 8.15M
March 31, 2022 10.29M
December 31, 2021 10.57M
September 30, 2021 10.95M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. 8.005B
TG Therapeutics, Inc. 552.25M
ACADIA Pharmaceuticals, Inc. 956.47M
Alnylam Pharmaceuticals, Inc. 3.308B
Anika Therapeutics, Inc. 38.41M